These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Is interferon only an antiviral agent? Burke DC Sci Prog; 1976; 63(249):141-6. PubMed ID: 1273570 [No Abstract] [Full Text] [Related]
43. [The medical significance of interferons and their inducers]. Ershov FI Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201 [TBL] [Abstract][Full Text] [Related]
44. The interferons and their inducers: molecular and therapeutic considerations. 1. Grossberg SE N Engl J Med; 1972 Jul; 287(1):13-9. PubMed ID: 4555144 [No Abstract] [Full Text] [Related]
45. From the NIH: Appearance of interferon in viral infections may cause asthma while controlling virus. JAMA; 1978 Sep; 240(12):1232. PubMed ID: 79662 [No Abstract] [Full Text] [Related]
49. The role of interferon in the regulation of virus infections by cytotoxic lymphocytes. Welsh RM; Yang H; Bukowski JF Bioessays; 1988 Jan; 8(1):10-3. PubMed ID: 2452630 [No Abstract] [Full Text] [Related]
50. [Interferon--its function and significance]. Norrby E Lakartidningen; 1972 Feb; 69(9):988-98. PubMed ID: 4622680 [No Abstract] [Full Text] [Related]
51. Interferon-induced alterations in cells: relevance to viral and nonviral diseases. Preble OT; Friedman RM Lab Invest; 1983 Jul; 49(1):4-18. PubMed ID: 6191121 [TBL] [Abstract][Full Text] [Related]
52. Antiviral and antiproliferative properties of interferons: mechanism of action. Esteban M; Paez E Prog Med Virol; 1985; 32():159-73. PubMed ID: 2410953 [No Abstract] [Full Text] [Related]
53. Historical brevium--viral interference and interferon. van Oss CJ Immunol Invest; 2004; 33(4):481-2. PubMed ID: 15624704 [No Abstract] [Full Text] [Related]
54. [Interferon, its properties and perspectives for its practical use]. Smorodintsev A Usp Sovrem Biol; 1966; 62(3):398-414. PubMed ID: 4881796 [No Abstract] [Full Text] [Related]
55. [The role of endogenous interferon in the defense against viral oncogenic diseases. Current status of our experiments]. de Maeyer-Guignard J Bull Cancer; 1970; 57(1):31-6. PubMed ID: 4317943 [No Abstract] [Full Text] [Related]
56. [Antiviral immunological therapeutics]. de Juan Martín F An Esp Pediatr; 1989 Sep; 31 Suppl 38():131-6. PubMed ID: 2484996 [No Abstract] [Full Text] [Related]
57. Interference by interferons: Janus faces in vascular proliferative diseases. Wessely R Cardiovasc Res; 2005 Jun; 66(3):433-43. PubMed ID: 15914108 [TBL] [Abstract][Full Text] [Related]
58. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses--and viruses counteract IFN action. Bonjardim CA Microbes Infect; 2005 Mar; 7(3):569-78. PubMed ID: 15792636 [TBL] [Abstract][Full Text] [Related]
59. Interferon induction. Can Med Assoc J; 1968 Jun; 98(22):1065-6. PubMed ID: 5652452 [No Abstract] [Full Text] [Related]
60. [Clinical significance of interferon reaction of leukocytes]. Shul'tsef GP Klin Med (Mosk); 1973 Oct; 51(10):19-21. PubMed ID: 4595428 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]